France’s National Agency for the Safety of Medicines and Health Products (ANSM) has confirmed significant supply shortages of 75 mg and 100 mg acetylsalicylic acid (aspirin) tablets. These medications will face distribution difficulties lasting until early 2027, necessitating authorized substitutions to ensure continuous patient care.
In Plain English: The Clinical Takeaway
- Substitution is authorized: Because of the shortage, the ANSM authorizes the substitution of these tablets.
- Do not stop your medication: These tablets are used against cardiovascular disorders.
- Consult your pharmacist: If your regular pharmacy is out of stock, they can guide you.
The Scope of the Current Supply Disruption
The current supply tension specifically impacts gastro-resistant aspirin tablets in 75 mg and 100 mg strengths. According to the ANSM, these formulations are used against cardiovascular disorders. The agency has reported strong supply tensions on these tablets.
The projected timeline for resolution—stretching into early 2027—indicates that these tensions should endure at least until that time.
Mechanism of Action and Clinical Necessity
Acetylsalicylic acid functions through the inhibition of the cyclooxygenase-1 (COX-1) enzyme. By blocking this enzyme, the drug prevents the synthesis of thromboxane A2, a mediator of platelet aggregation.
The "gastro-resistant" nature of these tablets is a key clinical feature. By coating the aspirin, the medication passes through the acidic environment of the stomach to dissolve in the small intestine.
| Factor | Clinical Significance |
|---|---|
| Primary Indication | Used against cardiovascular disorders |
| Mechanism | COX-1 inhibition |
| Dosage Range | 75 mg – 100 mg |
| Shortage Duration | Anticipated until early 2027 |
Contraindications & When to Consult a Doctor
Additionally, those who are unable to find an equivalent substitution at their local pharmacy should not attempt to "split" higher-dose aspirin tablets, as this can destroy the protective gastro-resistant coating.
Data Integrity and Regulatory Oversight
The ANSM’s decision to authorize substitutions is a measure designed to mitigate the risk of patient discontinuation.
References
- Agence nationale de sécurité du médicament et des produits de santé (ANSM). “Actualité – Fortes tensions d’approvisionnement sur les comprimés gastro-résistants à base d’acide acétylsalicylique (aspirine) 75 mg et 100 mg.”
